Related Experiment Videos
Chlamydia pneumoniae in vascular tissue
1Department of Genitourinary Medicine and Communicable Diseases, Imperial College School of Medicine at St Mary's, Paddington, London, UK.
Insights
Chlamydia pneumoniae bacteria have been definitively found in human atherosclerotic lesions across multiple studies. While their presence is confirmed, a direct causal link to atherosclerosis remains unproven.
Area of Science:
- Cardiovascular Research
- Infectious Diseases
- Pathology
Background:
- Atherosclerosis is a complex cardiovascular disease.
- The potential role of infectious agents in atherosclerosis is an area of ongoing research.
- Chlamydia pneumoniae is a bacterium that has been investigated for its association with cardiovascular conditions.
Purpose of the Study:
- To review and summarize the existing evidence on the presence of Chlamydia pneumoniae in human atherosclerotic lesions.
- To assess the extent and consistency of findings across different studies and geographical locations.
Main Methods:
- Systematic review of 17 publications on Chlamydia pneumoniae in atherosclerotic lesions.
- Analysis of evidence presented using various detection techniques.
- Examination of findings in different arterial locations (aorta, coronary, carotid, etc.).
Main Results:
- Evidence for Chlamydia pneumoniae presence in atherosclerotic tissue was found in 15 out of 17 reviewed publications.
- The bacterium was detected in various arteries, including aorta, coronary, and carotid.
- Chlamydia pneumoniae was found in 71% of atheromatous arteries and even in 67% of early atherosclerotic lesions (fatty streaks).
Conclusions:
- The presence of Chlamydia pneumoniae within atherosclerotic lesions is scientifically established.
- The youngest individuals with detectable organisms in their arteries were as young as 15-20 years old.
- A definitive causal role for Chlamydia pneumoniae in the development of atherosclerosis has not yet been conclusively demonstrated.
Abstract:
This review summarizes the evidence for the presence of Chlamydia pneumoniae organisms in atherosclerotic lesions. A total of 17 publications are mentioned concerning this topic. In all but two, both from the same group, evidence is presented by means of various techniques for the existence of the organisms in atherosclerotic tissue. Thus, they have been found in the aorta and in coronary, carotid, pulmonary, femoral and iliac arteries. In the first study in the UK, the aorta, femoral and iliac arteries were found to be positive for C. pneumoniae. In a recent study on autopsy specimens undertaken in conjunction with South African investigators, 71% of atheromatous arteries were positive for C. pneumoniae compared with only 9% of non-atheromatous arteries. Interestingly, the organisms were detected in 67% of the vessels showing only early atherosclerotic lesions (fatty streaks). The relationship between the age of the subject and the probability of detecting C. pneumoniae organisms is discussed; the youngest subjects with arteries positive for these organisms were aged 15 and 20 years. It is concluded that the presence of chlamydiae within atherosclerotic lesions is now beyond doubt, but as yet there is no conclusive evidence for a causal role in atherosclerosis.